FROESE GRANT enters HELUS PHARMA INC. with 161.26K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 10/23/2026ACC: 0000912282-26-001385
161.26K
Baseline shares
0.00
Direct ownership
0 positions
19.74K
Derivative underlying
1 instrument
2
Security positions
161.26K indirect
Non-Derivative Holdings2
Common Shares
IndirectShares owned156K
Common Shares
IndirectShares owned5.26K
Total
161.26K indirect161.26K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 156K | Indirect |
| Common Shares | 5.26K | Indirect |
| Total | 161.26K | 161.26K indirect |
Derivative Holdings1
Warrants
DirectUnderlying security
Common Shares
Underlying shares
19.74K
Shares owned
N/A
Exercise price
17.37
Expiration
—
Exercise window
—
Total
Underlying
19.74K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants Direct | Common Shares | 17.37 | — | — | 19.74K | N/A |
| Total | 19.74K | 0.00 | ||||